Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-1998 | 12-1997 | 12-1996 | |
Cash Flows From Operating Activities | |||
Net Income | -1,140 | 110 | 130 |
Depreciation Amortization | 200 | 0 | 0 |
Other Working Capital | -1,190 | 10 | 70 |
Other Operating Activity | 1,230 | -360 | -240 |
Operating Cash Flow | $-900 | $-240 | $-40 |
Cash Flows From Investing Activities | |||
PPE Investments | -140 | 0 | 0 |
Other Investing Activity | -3,710 | 30 | -6,320 |
Investing Cash Flow | $-3,850 | $30 | $-6,320 |
Cash Flows From Financing Activities | |||
Other Financing Activity | 5,960 | 0 | 7,050 |
Financing Cash Flow | $5,960 | $0 | $7,050 |
Beginning Cash Position | 80 | 760 | 70 |
End Cash Position | 1,290 | 540 | 760 |
Net Cash Flow | $1,200 | $-210 | $680 |
Free Cash Flow | |||
Operating Cash Flow | -900 | -240 | -40 |
Free Cash Flow | -900 | -240 | -40 |